Polymorphisms the Toll-like receptor 4 gene and their potential role in infectious diseases and chronic inflammatory disorders;A Toll-like receptor-4-génpolimorfizmusok, valamint lehetséges klinikai szerepük fertozésekben és krónikus gyulladásos betegségekben

Orvosi Hetilap

Volumn 149, Issue 38, 2008, Pages 1791-1799

  Reismann, Péter ^a,b   Rácz, Károly ^a   Tulassay, Zsolt ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Semmelweis Egyetem   (Hungary)

Author keywords

Atherosclerosis; Diabetes mellitus; Periodontitis; Polymorphism; Toll like receptor 4

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; FIBRONECTIN; HEAT SHOCK PROTEIN 60; OXIDIZED LOW DENSITY LIPOPROTEIN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ASTHMA; ATHEROSCLEROSIS; CHRONIC INFLAMMATION; DIABETES MELLITUS; ENTERITIS; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOPATHOGENESIS; INFECTION; INNATE IMMUNITY; PERIODONTITIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN POLYMORPHISM; REVIEW;

EID: 53849128576     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2008.28452     Document Type: Review

References (67)

1. Anderson, K. V., Bokla, L., Nusslein-Vollhard, C.: Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene products. Cell, 1985, 42, 791-798.
2. Gay, N. J., Keith, F. J.: Drosophila Toll and IL-1 receptor. Nature, 1991, 351, 355-356.
3. Medzhitov, R., Preston-Hurlburt P., Janeway C.: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 1997, 388, 394-397.
4. Muzio, M., Mantovani, A.: The Toll receptor family. Allergy, 2001, 56, 103-108.
5. Akira, S., Takeda, K., Kaisho, T.: Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immun., 2001, 2, 675-679.
6. Rock, F. L., Hardiman, G., Timans, J. C. és mtsai: A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA, 1998, 95, 588-593.
7. Muzio, M.: Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol., 2001, 166, 249-255.
8. Mitchell J. A., Paul-Clark, M. J., Clarke, G. W. és mtsai: Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. J. Endocrinol., 2007, 193, 323-330.
9. Marshak-Rothstein, A., Rifkin, I. R.: Immunologically active antigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol., 2007, 25, 419-441.
10. Prechl J., Prohászka Z., Füst Gy.: A hosokkfehérjék és a természetes immunitás sokrétu kapcsolata. Hum. Immunol., 2003, 2, 25-32.
11. Ohashi, K., Burkart, V., Flohé, S. és mtsai: Heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol., 2000, 164, 558-561.
12. Kiechl, S., Lorenz, E., Reindl, M. és mtsai: Toll-like receptor 4 polymorphisms and atherogenesis. New Engl. J. Med., 2002, 347, 185-192.
13. Poltorak, A.: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science, 1998, 282, 2085-2088.
14. Arbour, N. C., Lorenz, E., Schutte, B. C. és mtsai: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Gen., 2000, 25, 187-191.
15. Uematsu, S., Akira, S.: Toll-like receptors and type I interferons. J. Biol. Chem., 2007, 282, 15319-15323.
16. Armant, M. A., Fenton, M. J.: Toll-like receptors: a family of pattern recognition receptors in mammals. Genome Biol., 2002, 3, 30111-30116.
17. Kim, Y. S., Hwang, Y. J., Kim, S. Y. és mtsai: Rarity of TLR4 Asp299Gly and Thr399Ile polymorphisms in the Korean population. Yonsei Med. J., 2008, 49, 58-62.
18. El-Omar, E. M., Ng, M. T., Hold, G. L.: Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene, 2008, 27, 244-252.
19. Schwartz, D. A.: TLR4 and LPS hyporesponsiveness in humans. Int. J. Hyg. Environ. Health, 2002, 205, 221-227.
20. Rallabhandi, P., Bell, J., Boukhvalova, M. S. és mtsai: Analysis of TLR4 polymorphic variant: New insights into TLR4/MD-2/CD14 stoichiometry, structure and signaling. J. Immun., 2006, 177, 322-332.
21. Agnese, D. M., Calvano, J. E., Hahm, S. J., és mtsai: Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J. Infect. Dis., 2002, 186, 1522-1525.
22. Lorenz, E., Mira, J. P., Frees, K. L. és mtsa: Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch. Intern. Med., 2002, 162, 1028-1032.
23. Child, N. J., Yang, I. A., Pulletz, M. C. és mtsai: Polymorphisms in toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem. Soc. Trans., 2003, 31, 1028-1032.
24. Feterowski, C., Emmanuilidis, K., Miethke, T. és mtsai: Effects of functional toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology, 2003, 109, 426-431.
25. Read, R. C., Pullin, J., Gregory, S. és mtsai: A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J. Infect. Dis., 2001, 184, 640-642.
26. Allen, A., Obaro, S., Bojang, K. és mtsai: Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children. Pediatr. Infect. Dis. J., 2003, 22, 1018-1019.
27. Karoly, E., Fekete, A., Banki, N. és mtsai: Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children. Pediatr. Res., 2007, 61, 371-374.
28. Mockenhaupt, F. P., Cramer, J. P., Hamann, L. és mtsai: Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. USA, 2006, 103, 177-182.
29. Moens, L., Verhaegen, J., Pierik, M. és mtsai: Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease. Microbes Infect., 2007, 9, 15-20.
30. Ferwarda, B., Kibiki, G. S., Netea, M. és mtsai: The Toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS, 2007, 21, 1375-1377.
31. Hawn, T. R., Verbon, A., Janer, M. és mtsai: Toll-like receptor 4 polymorphisms are associated with resistance to Legionaires' disease. Proc. Natl. Acad. Sci. USA, 2005, 102, 2487-2489.
32. Tal, G., Mandelberg, A., Dalal, I. és mtsai: Association between common toll like receptor 4 mutations and severe respiratory syncytial virus disease. J. Infect. Dis., 2004, 189, 2057-2063.
33. Schwartz, D. A., Cook, D. N.: Polymorphisms of the Toll-like receptors and human disease. Clin. Inf. Dis., 2005, 41, S403-S407.
34. Raby, B. A., Klimecki, W. T., Laprise, C. és mtsai: Polymorphisms in Toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am. J. Respir. Crit. Care Med., 2002, 166, 1449-1456.
35. Fukata, M., Abreu, M. T.: TLR4 signalling in the intestine in health and disease. Biochem. Soc. Trans., 2007, 35, 1473-1478.
36. Török, H. P., Glas, J., Tonenchi, L. és mtsai: Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin. Immunol., 2004, 112, 85-91.
37. Ouburg, S., Mallant-Hent, R., Crusius, J. B. és mtsai: The Toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway. Gut, 2005, 54, 439-440.
38. Lakatos, P. L., Lakatos, L., Szalay, F. és mtsai: Toll-like receptor 4 and NOD/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J. Gastroenterol., 2005, 11, 1489-1495.
39. Bourhis, L. L., Benko, S., Girardin, S. E.: Nod1 and Nod2 in innate immunity and human inflammatory disorders. Biochem. Soc. Trans., 2007, 35, 1479-1485.
40. Edfeldt, K., Swedenborg, J., Hansson, C. K. és mtsa: Expression of toll-like receptors in human atherosclerotic lesions. Circulation, 2001, 105, 1158-1161.
41. Xu, X. H., Shah, P. K., Faure, E. és mtsai: Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation, 2001, 104, 3103-3108.
42. Hernesniemi, J. A., Raitakari, O. T., Kahönen, M. és mtsai: Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study. Atherosclerosis, 2008, 198, 152-159.
43. Hommels, M. J., Kroon, A. A., Netea, M. G. és mtsai: The Asp299Gly Toll-like receptor 4 polymorphism in advanced aortic atherosclerosis. Neth. J. Med., 2007, 65, 203-207.
44. Norata, G. D., Garlaschelli, K., Ongari, M. és mtsai: Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J. Intern. Med., 2005, 258, 21-27.
45. Labrum, R., Bevan, S., Sitzer, M. és mtsai: Toll receptor polymorphisms and carotid artery intima-media thickness. Stroke, 2007, 38, 1179-1184.
46. Boekholdt, S. M., Agema, W. R. P., Peters, R. J. G. és mtsai: Variants of Toll like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation, 2003, 107, 2416-2421.
47. Ameziane, N., Beillat, T., Verpillat, P. és mtsai: Association of the Toll like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler. Thromb. Vasc. Biol., 2003, 23, e61-64.
48. Kolek, M. J., Carlquist J. F., Muhlestein, J. B. és mtsai: Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes. Am. Heart J., 2004, 148, 1034-1040.
49. Reismann, P., Lichy, Ch., Rudofsky, G. és mtcai: Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia. J. Neurol., 2004, 251, 853-858.
50. Lalouschek, W, Sclillinger, M., Hsieh, K. és mtsai: Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin. Chem. Lab. Med., 2006, 44, 918-923.
51. Zee, R. Y., Hegener, H. H., Gould, J. és mtsa: Toll-like receptor 4 Asp299Gly polymorphism and risk of atherothrombosis. Stroke, 2005, 36, 154-157.
52. Beyan, H., Buckly, L. R., Yousaf, N. és mtsai: A role of innate immunity in type 1 diabetes. Diabet. Metab. Res. Rev., 2003, 19, 89-100.
53. Lang, K. S., Recher, M., Navarini, A. A. és mtsai: Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med., 2005, 11, 138-145.
54. Jonsson, A., Wales, J. K.: Blood glycoprotein levels in diabetes mellitus. Diabetologia, 1976, 12, 245-250.
55. McMillan, D. E.: Increased levels of acute-phase serum proteins in diabetes. Metabolism, 1989, 38, 1042-1046.
56. Illig, T., Bongardt, F., Schöpfer, A. és mtsai: The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes, 2003, 52, 2861-2864.
57. Rudofsky, G., Reismann, P., Witte, S. és mtsai: Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes. Diabet. Care, 2004, 27, 179-183.
58. Kinane, D. F.: Causation and pathogenesis of periodontal disease. Periodontol. 2000, 2001, 25, 8-20.
59. Darveau, R. P., Tanner, A., Page, R. C.: The microbial challenge in periodontitis. Periodontol. 2000, 1997, 14, 12-32.
60. Darveau, R. P., Arbabi, S., Garcia, I. és mtsai: Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation. Infect. Immun., 2002, 70, 1867-1873.
61. Laine, M. L., Morré, S. A., Murillo, L. S. és mtsai: CD14 and TLR4 Gene Polymorphisms in Adult Periodontitis. J. Dent. Res., 2005, 84, 1042-1046.
62. D'Aiuto, F., Parkar, M., Brett, P.M. és mtsai: Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine, 2004, 28, 29-34.
63. Folwaczny, M., Glas, J., Török, H. P. és mtsai: Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin. Exp. Immunol., 2004, 135, 330-335.
64. Schroder, N. W., Meister, D., Wolff, V. és mtsai: Chronic periodontal disease is associated with single-nucleotide polymorphisms of the human TLR-4 gene. Genes Immun., 2005, 5, 448-451.
65. Reismann, P., Lichy, Ch., Rudofsky, G. és mtsai: TLR4-polymorphisms and the risk of chronic periodontitis. Perio, 2007, 4, 41-45.
66. Schröder, N. W., Schumann, R. R.: Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis., 2005, 5, 156-164.
67. Misch, E. A., Hawn, T. R.: Toll-like receptor polymorphisms and susceptibility to human disease. Clin. Sci., 2008, 114, 347-360.